BNP Paribas Downgrades Medical Properties Trust (NYSE:MPW) to Neutral

Medical Properties Trust (NYSE:MPW) was downgraded by investment analysts at BNP Paribas from an “outperform” rating to a “neutral” rating in a research report issued on Tuesday, Marketbeat.com reports. They currently have a $4.00 target price on the real estate investment trust’s stock, down from their previous target price of $6.00. BNP Paribas’ price objective would indicate a potential downside of 1.36% from the company’s current price.

A number of other research firms have also recently commented on MPW. StockNews.com cut Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Saturday, May 18th. Truist Financial boosted their price target on Medical Properties Trust from $4.50 to $5.00 and gave the company a “hold” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft raised Medical Properties Trust from a “sell” rating to a “hold” rating and boosted their price target for the company from $2.00 to $5.00 in a report on Wednesday, April 17th. Colliers Securities lowered Medical Properties Trust from a “buy” rating to a “neutral” rating and cut their price target for the company from $10.00 to $4.25 in a report on Wednesday, April 10th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $5.00 price target on shares of Medical Properties Trust in a report on Tuesday, May 14th. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Medical Properties Trust has an average rating of “Hold” and a consensus price target of $5.61.

Medical Properties Trust Stock Up 0.6 %

MPW stock opened at $4.06 on Tuesday. Medical Properties Trust has a 1-year low of $2.92 and a 1-year high of $10.74. The business has a fifty day moving average price of $4.90 and a 200-day moving average price of $4.36. The company has a debt-to-equity ratio of 1.51, a current ratio of 3.10 and a quick ratio of 3.10. The stock has a market capitalization of $2.43 billion, a P/E ratio of -1.83, a P/E/G ratio of 0.62 and a beta of 1.27.

Institutional Investors Weigh In On Medical Properties Trust

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MPW. Bright Futures Wealth Management LLC. purchased a new stake in shares of Medical Properties Trust in the first quarter worth approximately $62,000. Keynote Financial Services LLC purchased a new stake in shares of Medical Properties Trust in the first quarter worth approximately $265,000. Goldentree Asset Management LP purchased a new stake in shares of Medical Properties Trust in the first quarter worth approximately $15,966,000. Cetera Advisors LLC grew its stake in Medical Properties Trust by 11.7% in the first quarter. Cetera Advisors LLC now owns 124,863 shares of the real estate investment trust’s stock worth $587,000 after purchasing an additional 13,107 shares in the last quarter. Finally, Cetera Investment Advisers grew its stake in Medical Properties Trust by 269.9% in the first quarter. Cetera Investment Advisers now owns 347,247 shares of the real estate investment trust’s stock worth $1,632,000 after purchasing an additional 253,365 shares in the last quarter. 71.79% of the stock is currently owned by hedge funds and other institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.